Report cover image

Global Antibody Drugs Market 2022-2028

Publisher Gen Consulting Company
Published May 13, 2022
Length 71 Pages
SKU # GCC17210344

Description

Global Antibody Drugs Market 2022-2028

An antibody is a protein component of the immune system that circulates in the blood, recognizes foreign substances like bacteria and viruses, and neutralizes them. After exposure to a foreign substance, called an antigen, antibodies continue to circulate in the blood, providing protection against future exposures to that antigen. According to latest analysis by Gen Consulting Company, the global antibody drugs market is poised to grow by USD 91 billion during 2022-2028, progressing at a CAGR of 9.7% during the forecast period.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global antibody drugs market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the antibody drugs industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, process, diseases, and region. The global market for antibody drugs can be segmented by product: chimeric mAbs, human mAbs, humanized mAbs, others. Human mAbs was the largest revenue contributor to the global antibody drugs market in 2021 and is anticipated to show the highest growth rate during the forecast period. Antibody drugs market is further segmented by process: mammalian cell culture, microbial fermentation. Based on diseases, the antibody drugs market is segmented into: autoimmune diseases, multiple myeloma, lymphoma, and leukemia, solid tumors, others. On the basis of region, the antibody drugs market also can be divided into: Asia Pacific, Europe, North America.

By product:
  • chimeric mAbs
  • human mAbs
  • humanized mAbs
  • others
By process:
  • mammalian cell culture
  • microbial fermentation
By diseases:
  • autoimmune diseases
  • multiple myeloma, lymphoma, and leukemia
  • solid tumors
  • others
By region:
  • Asia Pacific
  • Europe
  • North America
The report has also analysed the competitive landscape of the global antibody drugs market with some of the key players being AbbVie Inc., Acrotech Biopharma, LLC, Amgen Inc., AstraZeneca plc, Biogen Inc., Bristol-Myers Squibb Company (BMS), Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Johnson & Johnson, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi S.A., among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report
  • To analyze and forecast the market size of the global antibody drugs market.
  • To classify and forecast the global antibody drugs market based on product, process, diseases, region.
  • To identify drivers and challenges for the global antibody drugs market.
  • To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global antibody drugs market.
  • To identify and analyze the profile of leading players operating in the global antibody drugs market.
Why Choose This Report
  • Gain a reliable outlook of the global antibody drugs market forecasts from 2022 to 2028 across scenarios.
  • Identify growth segments for investment.
  • Stay ahead of competitors through company profiles and market data.
  • The market estimate for ease of analysis across scenarios in Excel format.
  • Strategy consulting and research support for three months.
  • Print authentication provided for the single-user license.

Table of Contents

71 Pages
PART 1. INTRODUCTION
Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
Introduction
Drivers
Restraints
Impact of COVID-19 pandemic
PART 5. MARKET BREAKDOWN BY PRODUCT
Chimeric mAbs
Human mAbs
Humanized mAbs
Others
PART 6. MARKET BREAKDOWN BY PROCESS
Mammalian cell culture
Microbial fermentation
PART 7. MARKET BREAKDOWN BY DISEASES
Autoimmune diseases
Multiple myeloma, lymphoma, and leukemia
Solid tumors
Others
PART 8. MARKET BREAKDOWN BY REGION
Asia Pacific
Europe
North America
PART 9. KEY COMPANIES
AbbVie Inc.
Acrotech Biopharma, LLC
Amgen Inc.
AstraZeneca plc
Biogen Inc.
Bristol-Myers Squibb Company (BMS)
Eli Lilly and Company
F. Hoffmann-La Roche AG
GlaxoSmithKline plc
Johnson & Johnson
Merck & Co. Inc.
Novartis AG
Pfizer Inc.
Sanofi S.A.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us